| Affymetrix Genome-wide Human SNP array 6.0 |
drug |
2 |
1 |
Affymetrix array 6.0 |
| Affymetrix Human Exon 1.0 ST array |
drug |
2 |
— |
Affymetrix Human Exon 1.0 ST |
| Affymetrix U219 |
drug |
2 |
1 |
|
| AFR |
cohort |
13 |
6 |
African, African ancestry, African cohort, West African ancestry |
| AFR ancestry |
cohort |
3 |
1 |
AFR, African ancestry |
| African |
cohort |
38 |
12 |
AFR, African, African ancestry, African individuals, African population, African samples, Africans |
| African American |
cohort |
149 |
88 |
1,710 African-American current or former smokers, 3,742 AAs, AA, AA abusers, AA adolescents, AA adults, AA cases, AA cohort, AA controls, AA families, AA females, AA participants, AA population, AA populations, AA sample, AA samples, AA subjects, AA women, AAs, AFA, AFR, ASW, African, African American, African American (AA) adolescents, African American (AA) females, African American adults, African American ancestry, African American families, African American former heroin addicts, African American individuals, African American participants, African American sample, African American subgroup, African American women, African American22, African American93, African Americans, African ancestries, African ancestry, African ancestry block, African ancestry cohort, African ancestry populations, African ancestry sample, African descent, African-American, African-American "abusers", African-American ethnicity, African-Americans, African–American samples, African–Americans, Black, Black or African American, Black participants, Black/African American, Blacks, admixed African American samples, admixed population, black men, blacks, blue, genetic AA, individuals of African ancestries, individuals of African ancestry, individuals of predominantly African ancestries, mean African ancestry |
| African-Americans |
cohort |
41 |
24 |
AA, AA controls, AA women, AAs, African American, African American population, African American sample, African Americans, African-American, African-American "control", African-American cohort, African-American participants, African-American sample, African-Americans, African-descent populations, Black, Black individuals in young adulthood, Black young adults, Blacks |
| African ancestry female twins |
cohort |
2 |
— |
African ancestry twins |
| African descent |
cohort |
7 |
2 |
African, people of African descent |
| African individuals |
cohort |
3 |
2 |
AA, African |
| African samples |
cohort |
5 |
2 |
African sample |
| agarose |
drug |
8 |
1 |
1% agarose, agarose gel |
| AGDS |
cohort |
3 |
1 |
Australian Genetics of Depression Study |
| age |
phenotype |
171 |
82 |
11 years, 12 years, 13 years, 14 years, 30–39 years, 40–49 years, 60–69 years, AGE, advancing age, age, age at assessment, age at disaster, age at interview, age group, age of respondents, age of the subject, baseline age, chronological age, mean age, older age, older age groups, older youth, participant age, respondent’s age, under 40, younger, younger age, younger age at baseline, younger participants |
| age 12 |
cohort |
3 |
1 |
12 years, age 12 |
| age 14 |
cohort |
2 |
2 |
14-year-old adolescents |
| age 16 |
cohort |
2 |
1 |
16 years |
| age 19–20 |
cohort |
2 |
1 |
19-20 years |
| Age 45-64 |
cohort |
2 |
1 |
45 to 64 years, individuals between 45 and 64 |
